IDEAYA BIOSCIENCES INC
IDYANASDAQ🏆 #1560 by market capUS Equity
$354.55▲ $25.24 (+7.12%)
🌙 After hours$37.86▼ 89.32%Simulated priceTrack IDYA
Get earnings, price moves & breaking news on Telegram
24h▲ 7.1%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$3.63B
Small Cap
📈Revenue Growth (YoY)
+3024.4%
High Growth
📊Gross Margin
-13.3%
Thin
💵FCF Margin
-81.2%
Thin
⚖️P/S Ratio
15.5x
Expensive
Otter Score
80
Good
IDEAYA BIOSCIENCES INC
IDYAAnalyst Ratings
Price
$354.55
Total
26
Raised
0
Lowered
1
Avg PT
$57.00
H / L
$63 / $48
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Guggenheim | Reiterated | Buy | 2026-09-09 | $57.00 | −83.90% |
Citizens | Reiterated | Market Outperform | 2026-09-01 | — | — |
Truist Securities | Reiterated | Buy | 2026-08-05 | — | — |
Wedbush | Reiterated | Outperform | 2026-08-05 | $60.00 | −83.10% |
RBC Capital | Reiterated | Outperform | 2026-07-07 | $48.00 | −86.50% |
Mizuho | Reiterated | Outperform | 2026-05-07 | — | — |
Goldman Sachs | Reiterated | Neutral | 2026-04-14 | $48.00 | −86.50% |
Wells Fargo | Reiterated | Overweight | 2026-04-14 | — | — |
Citigroup | Reiterated | Buy | 2026-02-19 | $58.00 | −83.60% |
JP Morgan | Reiterated | Overweight | 2025-10-23 | — | — |
BTIG | Reiterated | Buy | 2025-10-21 | $62.00 | −82.50% |
Stephens & Co. | Reiterated | Overweight | 2025-09-09 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2025-09-09 | — | — |
JMP Securities | Reiterated | Market Outperform | 2025-09-08 | $41.00 | −88.40% |
Leerink Partners | Downgraded | Outperform → Market Perform | 2024-11-05 | $27.00 | −92.40% |
Oppenheimer | Reiterated | Outperform | 2024-10-29 | $36.00 | −89.80% |
Stifel | Reiterated | Buy | 2024-09-10 | — | — |
Berenberg | Reiterated | Buy | 2023-03-23 | — | — |
Capital One | Reiterated | Overweight | 2022-12-28 | — | — |
Baird | Reiterated | Outperform | 2022-11-18 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2021-08-11 | — | — |
Roth Capital | Reiterated | Buy | 2021-04-19 | — | — |
Northland Capital Markets | Reiterated | Outperform | 2020-09-01 | — | — |
H.C. Wainwright | Reiterated | Buy | 2020-04-06 | — | — |
Jefferies | Reiterated | Buy | 2019-06-17 | — | — |
Citi | Reiterated | Buy | 2019-06-17 | — | — |
Institution
Guggenheim
Reiterated · Buy · 2026-09-09
$57.00
−83.90%
Citizens
Reiterated · Market Outperform · 2026-09-01
—
—
Truist Securities
Reiterated · Buy · 2026-08-05
—
—
Wedbush
Reiterated · Outperform · 2026-08-05
$60.00
−83.10%
RBC Capital
Reiterated · Outperform · 2026-07-07
$48.00
−86.50%
Mizuho
Reiterated · Outperform · 2026-05-07
—
—
Goldman Sachs
Reiterated · Neutral · 2026-04-14
$48.00
−86.50%
Wells Fargo
Reiterated · Overweight · 2026-04-14
—
—
Citigroup
Reiterated · Buy · 2026-02-19
$58.00
−83.60%
JP Morgan
Reiterated · Overweight · 2025-10-23
—
—
BTIG
Reiterated · Buy · 2025-10-21
$62.00
−82.50%
Stephens & Co.
Reiterated · Overweight · 2025-09-09
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2025-09-09
—
—
JMP Securities
Reiterated · Market Outperform · 2025-09-08
$41.00
−88.40%
Leerink Partners
Downgraded · Outperform → Market Perform · 2024-11-05
$27.00
−92.40%
Oppenheimer
Reiterated · Outperform · 2024-10-29
$36.00
−89.80%
Stifel
Reiterated · Buy · 2024-09-10
—
—
Berenberg
Reiterated · Buy · 2023-03-23
—
—
Capital One
Reiterated · Overweight · 2022-12-28
—
—
Baird
Reiterated · Outperform · 2022-11-18
—
—
HC Wainwright & Co.
Reiterated · Buy · 2021-08-11
—
—
Roth Capital
Reiterated · Buy · 2021-04-19
—
—
Northland Capital Markets
Reiterated · Outperform · 2020-09-01
—
—
H.C. Wainwright
Reiterated · Buy · 2020-04-06
—
—
Jefferies
Reiterated · Buy · 2019-06-17
—
—
Citi
Reiterated · Buy · 2019-06-17
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space